Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy

World Journal of Gastroenterology

Volumn 19, Issue 27, 2013, Pages 4400-4408

  Lei, Jian Yong ^a   Yan, Lu Nan ^a   Wang, Wen Tao ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Comparison; Complication; Downstage; Liver; Recurrence; Resection; Survival; Transplantation

Indexed keywords

ALPHA FETOPROTEIN; CYCLOSPORIN; TACROLIMUS;

ADULT; ARTICLE; CANCER SURVIVAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; RISK FACTOR; TUMOR DIFFERENTIATION; TUMOR RECURRENCE;

EID: 84880417152     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i27.4400     Document Type: Article

References (55)

1. Yang JD, Roberts LR. Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 2010; 7: 448-458[PMID: 20628345 DOI: 10.1038/nrgastro.2010.100]
2. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010; 42 Suppl 3: S206-S214[PMID: 20547305 DOI: 10.1016/S1590-8658(10)60507-5]
3. el-Serag HB. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001; 5: 87-107.[PMID: 11218921 DOI: 10.1016/S1089-3261(05)70155-0]
4. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108[PMID: 15761078 DOI: 10.3322/canjclin.55.2.74]
5. Merchant N, David CS, Cunningham SC. Early Hepatocellular Carcinoma: Transplantation versus Resection: The Case for Liver Resection. Int J Hepatol 2011; 2011: 142085[PMID: 21994848]
6. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699[PMID: 8594428 DOI: 10.1056/ NEJM199603143341104]
7. Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-totreat analysis. Hepatology 2008; 48: 819-827[PMID: 18688876 DOI: 10.1002/hep.22412]
8. Ravaioli M, Grazi GL, Piscaglia F, Trevisani F, Cescon M, Ercolani G, Vivarelli M, Golfieri R, D'Errico Grigioni A, Panzini I, Morelli C, Bernardi M, Bolondi L, Pinna AD. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 2008; 8: 2547-2557[PMID: 19032223 DOI: 10.1111/j.1600-6143.2008.02409.x]
9. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, Perrin H, Azoulay D. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688-701.discussion 701-703[PMID: 9409568 DOI: 10.1097/00000658-199712000-00006]
10. De Luna W, Sze DY, Ahmed A, Ha BY, Ayoub W, Keeffe EB, Cooper A, Esquivel C, Nguyen MH. Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. Am J Transplant 2009; 9: 1158-1168[PMID: 19344435 DOI: 10.1111/j.1600-6143.2009.02576.x]
11. Belghiti J. Transplantation for liver tumors. Semin Oncol 2005; 32: 29-32[PMID: 16360010 DOI: 10.1053/j.seminoncol. 2005.07.023]
12. Choti MA. Transplantation versus resection for hepatocellular carcinoma in the mild cirrhotic: framing the debate. J Gastrointest Surg 2009; 13: 1021-1022[PMID: 19333661 DOI: 10.1007/s11605-009-0868-9]
13. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, Tzakis AG, Van Thiel DH, Carr B, Selby R. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214: 221-228.discussion 221-228;[PMID: 1656903 DOI: 10.1097/00000658-199109000-00005]
14. Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg 1998; 227: 424-432[PMID: 9527066 DOI: 10.1097/00000658-199803000-00015]
15. Lee KK, Kim DG, Moon IS, Lee MD, Park JH. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol 2010; 101: 47-53[PMID: 19798686 DOI: 10.1002/jso.21415]
16. Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, Roberts J, Reich DJ, Schwartz ME, Mieles L, Lee FT, Florman S, Yao F, Harper A, Edwards E, Freeman R, Lake J. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010; 16: 262-278[PMID: 20209641 DOI: 10.1002/lt.21999]
17. Lewandowski RJ, Kulik LM, Riaz A, Senthilnathan S, Mulcahy MF, Ryu RK, Ibrahim SM, Sato KT, Baker T, Miller FH, Omary R, Abecassis M, Salem R. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 2009; 9: 1920-1928[PMID: 19552767 DOI: 10.1111/ j.1600-6143.2009.02695.x]
18. Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010; 252: 903-912[PMID: 21107100 DOI: 10.1097/ SLA.0b013e3181efc656]
19. Shi ZR, Yan LN, Li B, Wen TF. Evaluation of standard liver volume formulae for Chinese adults. World J Gastroenterol 2009; 15: 4062-4066[PMID: 19705504 DOI: 10.3748/wjg.15.4062]
20. Taketomi A, Kayashima H, Soejima Y, Yoshizumi T, Uchiyama H, Ikegami T, Yamashita Y, Harada N, Shimada M, Maehara Y. Donor risk in adult-to-adult living donor liver transplantation: impact of left lobe graft. Transplantation 2009; 87: 445-450[PMID: 19202452 DOI: 10.1097/TP.0b013e3181943d46]
21. Jiang L, Yan L, Li B, Wen T, Zhao J, Jiang L, Cheng N, Wei Y, Yang J, Xu M, Wang W. Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin. Am J Transplant 2010; 10: 1861-1869[PMID: 20659092 DOI: 10.1111/j.1600-6143.2010.03208.x]
22. Blum HE. Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol 2005; 11: 7391-7400[PMID: 16437707]
23. Cauchy F, Fuks D, Belghiti J. HCC: current surgical treatment concepts. Langenbecks Arch Surg 2012; 397: 681-695[PMID: 22290218 DOI: 10.1007/s00423-012-0911-2]
24. Lei J, Yan L. Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies. J Gastrointest Surg 2012; 16: 2120-2125[PMID: 22948843 DOI: 10.1007/s11605- 012-2019-y]
25. Belghiti J. Resection and liver transplantation for HCC. J Gastroenterol 2009; 44 Suppl 19: 132-135[PMID: 19148807]
26. Pelletier SJ, Fu S, Thyagarajan V, Romero-Marrero C, Batheja MJ, Punch JD, Magee JC, Lok AS, Fontana RJ, Marrero JA. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl 2009; 15: 859-868[PMID: 19642139 DOI: 10.1007/s00535-008-2250-1]
27. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002; 8: 873-883[PMID: 12360427 DOI: 10.1053/jlts.2002.34923]
28. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002; 235: 373-382[PMID: 11882759 DOI: 10.1097/00000658-200203000-00009]
29. Del Gaudio M, Ercolani G, Ravaioli M, Cescon M, Lauro A, Vivarelli M, Zanello M, Cucchetti A, Vetrone G, Tuci F, Ramacciato G, Grazi GL, Pinna AD. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant 2008; 8: 1177-1185[PMID: 18444925 DOI: 10.1111/ j.1600-6143.2008.02229.x]
30. Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, Decaens T, Hurtova M, Memeo R, Mallat A, Duvoux C. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 2009; 250: 738-746[PMID: 19801927 DOI: 10.1097/SLA.0b013e3181bd582b]
31. Scatton O, Zalinski S, Terris B, Lefevre JH, Casali A, Massault PP, Conti F, Calmus Y, Soubrane O. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation. Liver Transpl 2008; 14: 779-788[PMID: 18508370 DOI: 10.1002/lt.21431]
32. Bahirwani R, Reddy KR. Outcomes after liver transplantation: chronic kidney disease. Liver Transpl 2009; 15 Suppl 2: S70-S74[PMID: 19876956 DOI: 10.1002/lt.21900]
33. Herrero JI. De novo malignancies following liver transplantation: impact and recommendations. Liver Transpl 2009; 15 Suppl 2: S90-S94[PMID: 19877025]
34. Marino D, Burra P, Boccagni P, Calabrese F, Canova F, Trentin C, Boso C, Soldà C, Angeli P, Aversa SM. Post-transplant lymphoproliferative disorders in liver transplanted patients: a single-centre experience. Anticancer Res 2010; 30: 2383-2391[PMID: 20651397]
35. Bryce CL, Angus DC, Arnold RM, Chang CC, Farrell MH, Manzarbeitia C, Marino IR, Roberts MS. Sociodemographic differences in early access to liver transplantation services. Am J Transplant 2009; 9: 2092-2101[PMID: 19645706 DOI: 10.1111/j.1600-6143.2009.02737.x]
36. Bellavance EC, Lumpkins KM, Mentha G, Marques HP, Capussotti L, Pulitano C, Majno P, Mira P, Rubbia-Brandt L, Ferrero A, Aldrighetti L, Cunningham S, Russolillo N, Philosophe B, Barroso E, Pawlik TM. Surgical management of early-stage hepatocellular carcinoma: resection or transplantation? J Gastrointest Surg 2008; 12: 1699-1708[PMID: 18709418 DOI: 10.1007/s11605-008-0652-2]
37. Michel J, Suc B, Montpeyroux F, Hachemanne S, Blanc P, Domergue J, Mouiel J, Gouillat C, Ducerf C, Saric J, Le Treut YP, Fourtanier G, Escat J. Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol 1997; 26: 1274-1280[PMID: 9210614 DOI: 10.1016/S0168-8278(97)80462-X]
38. Mazziotti A, Grazi GL, Cavallari A. Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience. Hepatogastroenterology 1998; 45 Suppl 3: 1281-1287[PMID: 9730389]
39. Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P, Weber JC, Audet M, Doffoël M, Wolf P. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003; 9: 513-520[PMID: 12740796 DOI: 10.1053/jlts.2003.50070]
40. Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl 2005; 11: 1242-1251[PMID: 16184539 DOI: 10.1002/lt.20398]
41. Cunningham SC, Tsai S, Marques HP, Mira P, Cameron A, Barroso E, Philosophe B, Pawlik TM. Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis. Ann Surg Oncol 2009; 16: 1820-1831[PMID: 19267161 DOI: 10.1245/s10434-009-0364-1]
42. Jain A, Reyes J, Kashyap R, Rohal S, Abu-Elmagd K, Starzl T, Fung J. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Longterm follow-up of the first 1000 patients. Ann Surg 1999; 230: 441-448;discussion 441-448;[PMID: 10493490 DOI: 10.1097/ 00000658-199909000-00016]
43. De Carlis L, Giacomoni A, Pirotta V, Lauterio A, Slim AO, Bondinara GF, Cardillo M, Scalamogna M, Forti D. Treatment of HCC: the role of liver resection in the era of transplantation. Transplant Proc 2001; 33: 1453-1456[PMID: 11267370]
44. Cillo U, Vitale A, Brolese A, Zanus G, Neri D, Valmasoni M, Bonsignore P, Grigoletto F, Burra P, Farinati F, D'Amico DF. Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma. J Surg Oncol 2007; 95: 213-220[PMID: 17066432 DOI: 10.1002/jso.20641]
45. Shah SA, Cleary SP, Tan JC, Wei AC, Gallinger S, Grant DR, Greig PD. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann Surg Oncol 2007; 14: 2608-2614[PMID: 17522942 DOI: 10.1245/s10434-007-9443-3]
46. Shi XJ, Jin X, Wang MQ, Wei LX, Ye HY, Liang YR, Luo Y, Dong JH. Outcomes of loco-regional therapy for downstaging of hepatocellular carcinoma prior to liver transplantation. Hepatobiliary Pancreat Dis Int 2011; 10: 143-150[PMID: 21459720 DOI: 10.1016/S1499-3872(11)60023-4]
47. Zhou J, Wang Z, Qiu SJ, Huang XW, Sun J, Gu W, Fan J. Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation. J Cancer Res Clin Oncol 2010; 136: 1453-1460[PMID: 20148264 DOI: 10.1007/s00432-010-0802-2]
48. Chen DS, Sung JL. Serum alphafetoprotein in hepatocellular carcinoma. Cancer 1977; 40: 779-783[PMID: 70268 DOI: 10.1002/1097-0142(197708)40]
49. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236[PMID: 16250051 DOI: 10.1002/hep.20933]
50. Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M, Makuuchi M. alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology 2002; 35: 853-860[PMID: 11915031 DOI: 10.1053/jhep.2002.32100]
51. Shao YY, Lin ZZ, Hsu C, Shen YC, Hsu CH, Cheng AL. Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma. Cancer 2010; 116: 4590-4596[PMID: 20572033 DOI: 10.1002/cncr.25257]
52. Xu X, Ke QH, Shao ZX, Wu J, Chen J, Zhou L, Zheng SS. The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma. Dig Dis Sci 2009; 54: 385-388[PMID: 18563566 DOI: 10.1007/s10620-008-0349-0]
53. Zhou XD, Tang ZY, Yu YQ, Yang BH, Lu JZ, Lin ZY, Ma ZC, Zhang BH. Recurrence after resection of alphafetoprotein- positive hepatocellular carcinoma. J Cancer Res Clin Oncol 1994; 120: 369-373[PMID: 7511140 DOI: 10.1007/ BF01247463]
54. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, Makuuchi M. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38: 200-207[PMID: 12547409 DOI: 10.1016/S0168-8278(02)00360-4]
55. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998; 228: 479-490[PMID: 9790338 DOI: 10.1097/00000658-199810000-00005]